ECETOC Task Force reports on thresholds in chemical respiratory sensitisation
In common with all forms of allergic disease, chemical respiratory allergy develops in two phases. In the first phase, exposure to the inducing chemical allergen, via a relevant route, will cause immunological priming resulting in sensitisation of the respiratory tract. In the second phase, the now sensitised subject responds more vigorously if the same allergen is encountered again: the subject has become ‘sensitised’. Following inhalation exposure of the sensitised subject to the same chemical allergen, an inflammatory response will be provoked in the airways that in turn drives allergic disease.
The analyses by the Task Force have revealed that the acquisition of sensitisation of the respiratory tract to chemicals is dose-dependent and that thresholds do exist. However it is commonly difficult to define exactly what levels of exposure will be required for sensitisation to develop. It is clear that in some circumstances it may be possible to use occupational exposure data to derive levels of workplace exposure that are safe. However, the Task Force highlights the fact that there remains a need to develop improved methods for hazard characterisation.
Original publication
Other news from the department science
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.